GSK plc (BVMF:G1SK34)
Brazil · Delayed Price · Currency is BRL 62.68
+2.96 (4.96%)
At close: Feb 5, 2026
GSK plc Income Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 32,667 | 31,376 | 30,328 | 29,324 | 24,696 | |
Revenue Growth (YoY) | 4.12% | 3.46% | 3.42% | 18.74% | 1.40% |
Cost of Revenue | 8,947 | 8,845 | 8,388 | 9,407 | 8,033 |
Gross Profit | 23,720 | 22,531 | 21,940 | 19,917 | 16,663 |
Selling, General & Admin | 9,021 | 10,853 | 9,156 | 8,179 | 6,784 |
Research & Development | 6,650 | 6,078 | 5,823 | 5,153 | 4,627 |
Other Operating Expenses | -1,383 | -584 | -1,442 | -737 | -382 |
Operating Expenses | 14,288 | 16,347 | 13,537 | 12,595 | 11,029 |
Operating Income | 9,432 | 6,184 | 8,403 | 7,322 | 5,634 |
Interest Expense | -701 | -615 | -710 | -819 | -762 |
Interest & Investment Income | 169 | 132 | 108 | 62 | 13 |
Earnings From Equity Investments | 1 | -3 | -5 | -2 | 33 |
Other Non Operating Income (Expenses) | - | -63 | -74 | -44 | -6 |
EBT Excluding Unusual Items | 8,901 | 5,635 | 7,722 | 6,519 | 4,912 |
Merger & Restructuring Charges | -109 | -354 | -383 | -323 | -424 |
Gain (Loss) on Sale of Investments | - | 57 | -121 | 256 | 1 |
Gain (Loss) on Sale of Assets | - | 246 | 61 | 215 | 552 |
Asset Writedown | -880 | -314 | -398 | -296 | -347 |
Legal Settlements | - | - | - | 922 | - |
Other Unusual Items | -511 | -1,793 | -817 | -1,665 | -1,095 |
Pretax Income | 7,401 | 3,477 | 6,064 | 5,628 | 3,599 |
Income Tax Expense | 1,112 | 526 | 756 | 707 | 83 |
Earnings From Continuing Operations | 6,289 | 2,951 | 5,308 | 4,921 | 3,516 |
Earnings From Discontinued Operations | - | - | - | 10,495 | 1,069 |
Net Income to Company | 6,289 | 2,951 | 5,308 | 15,416 | 4,585 |
Minority Interest in Earnings | -573 | -376 | -380 | -460 | -200 |
Net Income | 5,716 | 2,575 | 4,928 | 14,956 | 4,385 |
Net Income to Common | 5,716 | 2,575 | 4,928 | 14,956 | 4,385 |
Net Income Growth | 121.98% | -47.75% | -67.05% | 241.07% | -23.73% |
Shares Outstanding (Basic) | 4,051 | 4,077 | 4,052 | 4,026 | 4,003 |
Shares Outstanding (Diluted) | 4,117 | 4,142 | 4,111 | 4,084 | 4,052 |
Shares Change (YoY) | -0.60% | 0.75% | 0.66% | 0.79% | 0.55% |
EPS (Basic) | 1.41 | 0.63 | 1.22 | 3.71 | 1.10 |
EPS (Diluted) | 1.39 | 0.62 | 1.20 | 3.66 | 1.08 |
EPS Growth | 123.15% | -48.12% | -67.26% | 238.48% | -24.16% |
Free Cash Flow | 6,393 | 5,155 | 5,454 | 6,260 | 7,002 |
Free Cash Flow Per Share | 1.55 | 1.25 | 1.33 | 1.53 | 1.73 |
Dividend Per Share | 0.660 | 0.610 | 0.580 | 0.613 | 1.000 |
Dividend Growth | 8.20% | 5.17% | -5.31% | -38.75% | - |
Gross Margin | 72.61% | 71.81% | 72.34% | 67.92% | 67.47% |
Operating Margin | 28.87% | 19.71% | 27.71% | 24.97% | 22.81% |
Profit Margin | 17.50% | 8.21% | 16.25% | 51.00% | 17.76% |
Free Cash Flow Margin | 19.57% | 16.43% | 17.98% | 21.35% | 28.35% |
EBITDA | 13,210 | 8,313 | 10,304 | 9,293 | 7,756 |
EBITDA Margin | 40.44% | 26.50% | 33.98% | 31.69% | 31.41% |
D&A For EBITDA | 3,778 | 2,129 | 1,901 | 1,971 | 2,122 |
EBIT | 9,432 | 6,184 | 8,403 | 7,322 | 5,634 |
EBIT Margin | 28.87% | 19.71% | 27.71% | 24.97% | 22.81% |
Effective Tax Rate | 15.02% | 15.13% | 12.47% | 12.56% | 2.31% |
Advertising Expenses | - | 851 | 835 | 735 | 433 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.